Bayer MaterialScience acquires remaining shares in the systems house joint venture Baulé
The FINANCIAL -- Effective March 31, Bayer MaterialScience will acquire the remaining shares in the 50:50 systems house joint venture Baulé SAS from EXIMIUM SAS and other shareholders.
The joint venture was established in 2008 by the Leverkusen-based company and Michel Baulé SA, which later was renamed EXIMIUM SAS. Baulé SAS is a global leader in the development, formulation and processing of polyurethane cast elastomers. According to Bayer AG, based in Romans, France, the company has subsidiaries in the United States, the United Kingdom, France and China. The transaction affects 139 employees, all of whom will be retained. Financial details have not been disclosed.
BASF expands in Indonesia with new polyurethanes laboratories
From: PUWORLD独家发布 / 3/30/2012 9:02:13 AM
BASF, the world’s leading chemical company, has launched new laboratories for Polyurethanes (PU) at its Cimanggis site in Indonesia. This expansion will further strengthen the company’s technical service network in the ASEAN region.
Housed in the BASF Technical Service Center at Cimanggis, the new laboratories are designed to enhance the quality and efficiency of technical services, including the analysis of polyurethane system performance, reactivity and physical foam testing. BASF’s application engineers can provide customized solutions by adjusting the system formulation to meet specific needs, thereby saving customers time and money.
"Indonesia, already the largest economy in Southeast Asia, needs the right innovative materials and solutions to support its continued growth,” said Henry Choo, President Director, PT BASF Indonesia. "Polyurethanes are a crucial for products such as shoes, energy efficient refrigerators and building insulation materials, cars and motorcycles. With these new laboratories, we will be able to offer fast, local support and stay closer to customers, to help them address industry challenges such as the need for better production efficiency and more environmentally-friendly solutions.”
“The world of polyurethane systems is highly service-oriented and depends heavily on the expertise and competence of its service providers. As a global leader in polyurethanes, we enable customers in every part of the world to have access to the technical support and service they need to optimize their product applications," said Mr. HyoungSoon Moon, Vice President of Polyurethanes in Asia Pacific. "The new technical laboratory allows us to serve local customers with comprehensive, tailored PU solutions through a reliable, single global supplier. The strong growth and demand in this region has provided us with compelling reasons to invest in the technical facilities and experts in this area. These investments will help to boost the ASEAN region into one of the fastest-growing markets in the polyurethane industry within the next decade."
Ludwigshafen (Germany) and Chelmsford (Massachusetts) – March 30, 2012 – BASF Venture Capital GmbH has invested $2.7 million in the advanced materials company FRX Polymers, Inc. The investment is part of a series B financing round of $26.7 million. FRX Polymers develops and produces innovative, non-halogen flame-retardant polymers.
“The polymeric flame retardants of FRX Polymers have unique properties,” explained Dr. Oliver Guthmann, Investment Manager at BASF Venture Capital. They consist of organic polymers with phosphorus as the active component. “Because of their polymeric structure, the flame retardants do not migrate out over time and also do not change the optical and mechanical properties of the plastic in which they are incorporated,” added Guthmann. Moreover, they can also be used as plastic themselves. This makes it possible to manufacture thin transparent high heat products, such as electronic sheet and LED light diffusers. A further advantage is that the flame retardants from FRX Polymers are halogen-free and thus particularly sustainable.
The flame retardants are already used in numerous products in the plastic processing industry – for example computer or monitor housings. FRX Polymers is currently operating three pilot plants: two in Chelmsford, Massachusetts, and another, larger facility in Switzerland. “The demand for our outstandingly environment-friendly products is increasing sharply,” said Marc Lebel, Chief Executive Officer of FRX Polymers. “We will therefore be using the funds from the financing round to further expand our new production plant in Antwerp and our sales operations.”
About FRX Polymers
FRX Polymers, Inc. was founded in 2007 following over five years of intensive research and development in the field of inherently flame retardant plastics. The company operates two pilot plants in Chelmsford, Massachusetts, and a polymer pilot plant in Switzerland recently commissioned in mid-2010. FRX is in the growth phase of its evolution and is commercializing a novel family of non-halogen, transparent, high melt flowing, fire resistant plastics. FRX Polymers is headquartered in Chelmsford, Massachusetts . More information is available at www.frxpolymers.com .
March 29, 2012
TDI PRICE ACTION
Dear Valued Customer:
Effective immediately, or as soon thereafter as the applicable contract allows, The Dow
Chemical Company (“Dow”) will increase its price for VORANATE™ TDI by
US$0.15/pound in the United States.
All other contract terms and conditions remain in full force and effect, and orders must
comply with established monthly sales levels and contract commitments. Your Dow
sales representative will be contacting you in order to answer any questions you might
have and to review your sales plan volumes.
Dow appreciates your business, and we look forward to our continued relationship.
Ludwigshafen, Germany - March 29, 2012 - BASF is realigning its research and is focusing even more strongly on the market and the global customer industries. Alongside the further development of the established business portfolio, the main research emphasis is being placed on growth and technology fields that address social challenges and offer BASF relevant business potential. This new orientation is based on BASF's "We create chemistry" strategy through which the company is intensifying its focus on sustainability and innovation as growth drivers. For 2012, BASF is planning to increase its research and development spending to €1.7 billion (previous year 2011: €1.6 billion). "To seize growth opportunities we are systematically expanding our product and technology portfolio, establishing an even more global presence and increasing our efforts to develop solutions for a sustainable future," said Dr. Andreas Kreimeyer, member of the Board of Executive Directors of BASF and Research Executive Director at today's Research Press Conference in Ludwigshafen, Germany.
In 2020, BASF wants to achieve sales of around €30 billion with products that have not been on the market for longer than ten years. To accomplish this, BASF is strengthening its collaboration with key industries and concentrating on growth fields relevant to society such as "heat management", "water treatment" and "organic electronics". These are new business areas for BASF with high growth potential. At the same time, enabling technologies have been defined - such as raw material change, material systems and nanotechnology as well as white biotechnology - which are needed to generate solutions for the growth fields.
In order to implement the new orientation most effectively, the research platforms have been tailored to the various business and technology areas and assigned specific topics. Thus, the activities of the platform "Process Research & Chemical Engineering" concentrate on new technologies, processes and catalysis. The topics crop protection, organic electronics and white biotechnology are being pursued in the research division "Biological & Effect Systems Research". In the research platform "Advanced Materials & Systems Research", activities are focused mainly on new polymeric materials and system solutions and the fourth platform "Plant Science", is continuing its research into plant biotechnology.
In addition, BASF Future Business, which opens up new business areas for the company, is being expanded. It is responsible for developing and marketing business areas new for BASF. At present, the focus is on the topics "energy management", "organic electronics" and "medical solutions." In addition,BASF Venture Capital, a subsidiary of BASF Future Business, is investing in start-up companies specializing in innovative chemistry and system solutions in BASF's growth and technology fields.
"The aim of the new structure is to significantly expand our portfolio of functionalized materials and system solutions and continue improving our position in the emerging markets," explained Kreimeyer. "We want to strengthen our technological and operational excellence, create value from interdisciplinary innovations and position our activities on a global scale to meet the needs of the markets."
Solutions from chemistry for better health
One of the customer industries on which BASF will be concentrating further in future is the branch "Health and Nutrition". BASF already supplies numerous products for this market. With the introduction of new photostable UV filters for instance the company has established itself as a global technology and market leader. About every second sunscreen product contains BASF's UV absorbers. Two important innovations are the broadband UV filters Tinosorb® S and Tinosorb® M, which protect the skin against both UVA and UVB rays. Tinosorb S is an oil-soluble, organic UV absorber which is also used in daily care products. With Tinosorb M, BASF has the first and only insoluble, organic UV absorber on the market. It is often used in products with a high sunscreen factor and in sun creams for children.
BASF is also making a significant contribution in the health sector with its pharmaceutical excipients. The bioavailability of pharmaceutically active substances is a topic of growing importance because active substances are becoming ever more complex, often with an associated loss of solubility. The body cannot absorb undissolved active substances. With Soluplus®, BASF has developed a polymeric solubilizer which can also make high active substance concentrations available for the body. Another new polymer is the tablet coating system Kollicoat® Smartseal 30 D, the first polymer for this application which is marketed as an aqueous solution. Kollicoat Smartseal 30 D protects the active substance against moisture and masks the bitter taste of some active agents because the coating does not dissolve until it reaches the stomach.
The topic "water" also plays a central and increasing important role in the health sector. The need for clean water is increasing because of the growing world population and industrialization. Worldwide consumption of this resource has increased tenfold over the past 100 years. BASF's products and solutions for water treatment include flocculating and coagulating agents for waste water treatment and also membranes for (ultra)filtration, for example of drinking water, an area of work that BASF also establishes with the acquisition of inge watertechnologies in 2011. The plastic membranes also contain pores that are only 20 nanometers in size, allowing germs, bacteria and even viruses to be filtered out of the water. BASF estimates the market in the growth field water of €20 billion, representing a growth potential of more than €800 million.
More innovative strength through global research
"Effective and efficient research is an important success factor for achieving our growth targets and is simultaneously a factor distinguishing us from our competitors. Research and development will therefore have even greater priority in future than before," emphasized BASF's Research Executive Director. In 2011, the number of employees working in research and development increased to around 10,100 (previous year 2010: 9,600). In the markets of North and South America as well as Asia that are important for the chemicals business, however, BASF research is still underrepresented. "We will have to expand our presence and speed up our activities in these regions." A first step in this direction is the new Innovation Campus in Shanghai scheduled to open at the end of this year. "By creating innovations in Asia for Asia, we want to grow with our customers. By 2020, we want to double our research activities in Asia and the Americas and conduct 50 percent of our research and development outside Europe," explained Kreimeyer.
An important asset for globalized research is an international network of outstanding external researchers. BASF is already working in around 1,950 cooperations worldwide with universities, research institutes, start-ups and partners from industry. One example is the "Joint Research Network in Advanced Materials and Systems" (JONAS), a new initiative for researching functional materials in partnership with the universities of Strasbourg and Freiburg as well as ETH Zurich. "An extensive network of this type is indispensable to rapidly develop and market products that are durable, suitable for everyday use and affordable," emphasized Kreimeyer.
For more information about the new research strategy, please go to: http://www.basf.com/group/research
Orthopedic Dog Bed With Designer Fabric Cover
Guelph, Ontario (PRWEB) March 29, 2012
Eden Dog Beds, an Ontario-based manufacturer and distributor of luxury dog furniture, has just unveiled its new line of memory foam dog beds.
Memory foam dog beds are the only ones that are offer complete orthopedic support because memory foam acts as a shock absorber. Unlike other "filler" substances, it takes pressure off of joints and muscles, and as a result, reduces stiffness and soreness. When a dog sleeps on memory foam, his weight is more evenly distributed, and the memory foam contours to his specific shape.
Orthopedic dog beds aren't just for aging or injured dogs, though. Young, large dogs can experience pain and discomfort because of their sheer size. The right orthopedic dog beds can even be used to prevent arthritis from developing in younger dogs of all sizes.
With prices starting at $129, Eden's orthopedic dog bed customers will get their choice of either a medium or large size bed, and they'll get to choose from a variety of decorative covers. Each of Eden's memory foam dog beds also comes with:
Eden officials say it's important to pick a bed that's large enough to accommodate dogs' shoulders and hips in any position - and, when in doubt, opt for a larger size.
For more information, log onto http://www.edendogbeds.com or call (519) 780-1341.
Ciech to sell Polish TDI plant
From: PUWORLD独家发布 / 3/29/2012 10:22:09 AM
Polish chemical company Ciech Group has announced plans to sell its subsidiary Zachem, which manufactures TDI. The organic compound is used in polyurethane production.
“We are thinking about selling our TDI business,” said Ryszard Kunicki, chief executive of Ciech. “The recent reorganisation of Zachem, which is to focus solely on TDI production, is a clear sign that we are looking for bids from potential investors.”
The plan to sell Zachem has the endorsement of the plant’s employees and trade unions, Kunicki said.
Headquartered in Bydgoszcz, Poland, Zachem is the country’s only producer of TDI. The production facility has a workforce of about 1,200.
Ciech completed its reorganisation in 2011 but the company’s financial results were affected by the decreasing profitability of TDI production, the group said in a statement. Last year, TDI prices fell by about 13.5%, while production costs increased by some 23%, the statement said.
“The effects of our efforts from 2011 will become visible this year,” Kunicki said.
In 2011, Ciech reported revenues of 4.2bn zloty (€1.01bn), up 5.4% over a year earlier, and an operating profit of 119m zloty (€28.6m), down from 144.2m zloty (€34.7m) in 2010, according to figures from the Polish chemical business.
Set up in 1945, Ciech is based in Warsaw, Poland. The group’s product range includes PVC, PE foam, polyester resins, epoxy resins, epichlorohydrin (ECH), as well as various nitrogen fertilisers.
The Polish Treasury’s 44.15% share in Ciech is estimated to be worth over 370m zloty (€88.9m). Other major shareholders include investment fund Pioneer Pekao Investment Management, with a 9.99% share, and private pension fund ING OFE, with a 5.31% stake in the chemical group.